Mueller T C, Nielsen H, Nowak P. "一种来迪派韦的合成方法" [P]. European Patent, EP 3840052 A1, 2020-11-16.
发明人林芳,沈红梅,刘建华. "Method for the Synthesis of Ledipasvir Impurity 47" [P]. 中国发明专利, 专利号 CN 111693049 A, 授权公告日 2019-07-06.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 来迪派韦 in Pharmaceutical Formulations". J. Sep. Sci., 2018, 996, (8), 3374-3384.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来迪派韦 as an Impurity". Anal. Methods, 2019, 1076, 436-447.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Ledipasvir Impurity 47 Using HRMS and NMR". Chemosphere, 2025, 576, (2), 9775-9793.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 来迪派韦 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2015, 469, (2), 4070-4098.